Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer
NCT ID: NCT05842031
Last Updated: 2025-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
20 participants
OBSERVATIONAL
2023-04-14
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Linking In With Advice and Supports for Men Impacted by Metastatic Cancer
NCT05946993
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
NCT01031602
The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study
NCT03345264
Onco-primary Care Networking to Support TEAM-based Care
NCT04258813
Ambulatory Cancer Pain Management: A Feasibility Study
NCT00507351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary Objective:
To understand the lived experience of patients undergoing invasive inguinal lymph node procedures.
Secondary Objective:
To determine factors that influence decisions and improve experience for patients who need invasive inguinal lymph node procedures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Semi-structured interviews
Participants with penile cancer who have undergone invasive inguinal lymph node procedure will be recruited to participate in study via telephone recruitment.
Quality of Life Questionnaires
Identify what interventions may be helpful in improving quality of life.
Patient Educational Needs
Identify what interventions may be helpful in improving patient educational needs
Symptom Management
Identify what interventions may be helpful in improving symptom management Improve symptom management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality of Life Questionnaires
Identify what interventions may be helpful in improving quality of life.
Patient Educational Needs
Identify what interventions may be helpful in improving patient educational needs
Symptom Management
Identify what interventions may be helpful in improving symptom management Improve symptom management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who have not undergone invasive surgical procedures involving the inguinal lymph nodes
* Non-English-speaking patients For interviews: people who are physically and/or cognitively incapable of participating in a 60minute telephone interview as determined by a clinical provider or the patient.
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Curtis Pettaway, BS, MD
Role: PRINCIPAL_INVESTIGATOR
MD Anderson
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MD Anderson
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2023-03504
Identifier Type: REGISTRY
Identifier Source: secondary_id
2023-0112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.